GlassScriptPhysician profile
Christopher George Trahan
NPI 1952514382
$862.34
in general payments reported to CMS, 2019-2025
11 companies · $95.12 in 2025
The $95.12 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $17.24 · 2021: $70.67 · 2022: $57.36 · 2023: $298 · 2024: $194 · 2025: $95.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $181.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $168.34 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Baxter Healthcare | $165.47 | 2019-2023 | |
| Dilon Technologies, INC. | $98.09 | 2024-2025 | Hemoblast Bellows |
| Allergan, INC. | $68.55 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $65.04 | 2021-2024 | Exparel, Iovera |
| Innovation Technologies INC | $28.23 | 2024 | Irrisept |
| Coopersurgical, INC. | $27.96 | 2021 | |
| Zimmer Biomet Holdings, INC. | $24.14 | 2019 | |
| Medtronic, INC. | $19.33 | 2025 | Bis |
| Cook Medical LLC | $15.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Trahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.